10|1|2018
17:37 Farmaindustria
The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System
4|1|2017
13:53 Farmaindustria
The agreement is the result of a sustained dialogue and positive experience from the Protocol signed in 2015 and will be in force throughout 2017
| We innovate for people